Read + Share
Tinajero J, Ngo D, Salhotra A, Koller P, et al. Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In
Relapsed and Refractory Acute Myeloid Leukemia Patients. Acta Haematol 2023;146:538-542.
PMID: 37708871
|
 |
|
Tinajero J, Ngo D, Salhotra A, Koller P, et al. Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In
Relapsed and Refractory Acute Myeloid Leukemia Patients. Acta Haematol 2023;146:538-542.
PMID: 37708871
|
|
|
|